跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,305 条关于
“KRAS inhibitors”
全部
15,305
临床试验
7,465
药物
3,401
机构
9
资讯
4,430
去年
KRAS Inhibitors Market Set for Growth with Novel Therapies Targeting Key Mutations in Cancer
6个月前
Quanta Therapeutics' Direct KRAS Inhibitors Show Promise Against Resistance to Pan-RAS Tri-Complex Therapies
6个月前
BlossomHill Therapeutics Unveils Next-Generation Pan-KRAS Inhibitors with Picomolar Potency at AACR 2026
去年
KRAS Inhibitors Market Set to Exceed $2 Billion by 2030 with Next-Generation Therapies Advancing
去年
KRAS Inhibitor Market to Reach $186.4 Million by 2033, Driven by Targeted Cancer Therapies
去年
Amgen Develops Pan-KRAS Inhibitor AMG 410 to Target Broader Range of KRAS-Mutant Tumors
11个月前
ESMO 2025 Showcases Promising First-in-Human Data for KRAS G12C and FGFR3 Inhibitors
2年前
Advancements in Neuroplastogens, KRAS G12C Inhibitors, and Other Therapies Highlighted by Recent Deals and Clinical Readouts
去年
Alterome Therapeutics Initiates Phase 1 Trial of Novel Pan-KRAS Inhibitor ALTA3263 for Advanced Solid Tumors
去年
Venetoclax Enhances KRAS Inhibitor Efficacy in Pancreatic Cancer Models
第 1 页,共 443 页
上一页
下一页